3901 BARRETT DRIVE, RALEIGH, NC, UNITED STATES, 27609
國家
--
上市日期
--
財年截止
十二月
流通股數
0
CIK
--
官方網址
--
Vogenx, Inc. 是一家臨床階段藥物開發公司,專注開發針對代謝性疾病(包括減重術後低血糖症,即 PBH)及胃輕癱的療法。公司總部位於北卡羅來納州羅利。
財務指標
營業收入
2026-06-30
$0
2026-03-31
$0
2025-06-30
$0
2025-03-31
$0
營業支出
2026-06-30
$355.38K
2026-03-31
$463.15K
2025-06-30
$310.66K
2025-03-31
$372.19K
淨利潤
2026-06-30
-$384.43K
2026-03-31
-$475.45K
2025-06-30
-$294.79K
2025-03-31
-$356.61K
淨利潤率
2026-06-30
--
2026-03-31
--
2025-06-30
--
2025-03-31
--
每股收益
2026-06-30
$-0.07
2026-03-31
--
2025-06-30
--
2025-03-31
--
息稅折舊攤銷前利潤
2026-06-30
-$355.38K
2026-03-31
-$463.15K
2025-06-30
-$310.66K
2025-03-31
-$372.19K
有效稅率
2026-06-30
--
2026-03-31
--
2025-06-30
--
2025-03-31
--
項目
2026-06-30
2026-03-31
2025-06-30
2025-03-31
營業收入
$0
$0
$0
$0
營業支出
$355.38K
$463.15K
$310.66K
$372.19K
淨利潤
-$384.43K
-$475.45K
-$294.79K
-$356.61K
淨利潤率
--
--
--
--
每股收益
$-0.07
--
--
--
息稅折舊攤銷前利潤
-$355.38K
-$463.15K
-$310.66K
-$372.19K
有效稅率
--
--
--
--
常見問題
VOGX is a publicly traded security that tracks a portfolio of companies rather than representing a single operating business. Its value reflects the combined market performance of the underlying holdings, which may include equities from a specific sector, region, or investment theme. Investors can research its objectives, holdings, and structure through the fund's official documents, such as the prospectus and fact sheet, which outline its strategy and potential risks.
VOGX can be influenced by broad market sentiment, interest rate changes, economic data, and geopolitical events. Because it holds a basket of securities, the performance of its underlying components and their respective sectors also plays a significant role. Additionally, fund-specific factors such as expense ratio, tracking difference, liquidity, and investor flows can affect its market price. Monitoring these elements helps investors understand what may drive VOGX's movement.
The most current VOGX price is available on its stock detail page, which displays real-time or delayed quotes along with trading volume and daily price changes. For historical closing prices and intraday charts, investors can also use brokerage platforms, financial websites, or the fund sponsor's official site. Always rely on the latest displayed data rather than outdated figures when evaluating VOGX.
Valuation for VOGX typically involves examining metrics such as the price-to-earnings ratio, price-to-book ratio, and distribution yield of its underlying holdings. Investors may also compare these metrics against relevant benchmarks or peer funds to gauge relative value. Since VOGX is an ETF, its net asset value (NAV) and market price premium or discount are key considerations. Reviewing the fund's methodology and portfolio composition provides context for these valuation measures.
VOGX carries market risk, meaning its value can decline due to adverse movements in the underlying securities. Sector concentration, if applicable, may amplify volatility, while interest rate changes can affect rate-sensitive holdings. Liquidity risk could impact trading, especially during stressed markets, and tracking error may cause returns to deviate from the index. Investors should review the fund's prospectus for a full list of risks specific to its strategy.
Key metrics for VOGX include expense ratio, which reflects annual operating costs, and tracking difference, which measures how closely the fund follows its index. Distribution yield indicates income potential, while assets under management and average daily volume help assess liquidity. The price-to-earnings and price-to-book ratios of the portfolio offer valuation insight. Reviewing these data points alongside the fund's objective supports a more informed analysis.